These findings suggest variations in GPC1 mRNA and mProtein expression levels between EV subpopulations dominated by exosomes (captured using CD63, CD81, and CD9 antibodies) and tumor‐associated EVs (captured using EGFR, EpCAM, or GPC1 antibodies). This evidence concerns the gene CD9 and neoplasm.